161 related articles for article (PubMed ID: 24909440)
1. [Resistance to fluoroquinolones in 2013: what are the consequences in internal medicine?].
de Lastours V; Fantin B
Rev Med Interne; 2014 Sep; 35(9):601-8. PubMed ID: 24909440
[TBL] [Abstract][Full Text] [Related]
2. Impact of fluoroquinolones on human microbiota. Focus on the emergence of antibiotic resistance.
de Lastours V; Fantin B
Future Microbiol; 2015; 10(7):1241-55. PubMed ID: 26119580
[TBL] [Abstract][Full Text] [Related]
3. Emergence of quinolone resistance in the microbiota of hospitalized patients treated or not with a fluoroquinolone.
de Lastours V; Chau F; Roy C; Larroque B; Fantin B
J Antimicrob Chemother; 2014 Dec; 69(12):3393-400. PubMed ID: 25063781
[TBL] [Abstract][Full Text] [Related]
4. [The rational use of fluoroquinolones].
Zhang Y
Zhonghua Nei Ke Za Zhi; 1999 Jan; 38(1):7-8. PubMed ID: 12795261
[No Abstract] [Full Text] [Related]
5. The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?
Feliciano J; Teper E; Ferrandino M; Macchia RJ; Blank W; Grunberger I; Colon I
J Urol; 2008 Mar; 179(3):952-5; discussion 955. PubMed ID: 18207185
[TBL] [Abstract][Full Text] [Related]
6. [Impact of fluoroquinolone use on multidrug-resistant bacteria emergence].
Nseir S; Ader F; Marquette CH; Durocher A
Pathol Biol (Paris); 2005; 53(8-9):470-5. PubMed ID: 16176863
[TBL] [Abstract][Full Text] [Related]
7. Highlights on the appropriate use of fluoroquinolones in respiratory tract infections.
Blasi F; Tarsia P; Aliberti S; Santus P; Allegra L
Pulm Pharmacol Ther; 2006; 19 Suppl 1():11-9. PubMed ID: 16310389
[TBL] [Abstract][Full Text] [Related]
8. Appropriate antibiotic use and why it is important: the challenges of bacterial resistance.
Lieberman JM
Pediatr Infect Dis J; 2003 Dec; 22(12):1143-51. PubMed ID: 14688589
[TBL] [Abstract][Full Text] [Related]
9. Fluoroquinolone consumption and resistance in haematology-oncology patients: ecological analysis in two university hospitals 1999-2002.
Kern WV; Steib-Bauert M; de With K; Reuter S; Bertz H; Frank U; von Baum H
J Antimicrob Chemother; 2005 Jan; 55(1):57-60. PubMed ID: 15574472
[TBL] [Abstract][Full Text] [Related]
10. [Which partner for the betalactam agent in empiric combined therapy? I Fluoroquinolone].
Bedos JP
Ann Fr Anesth Reanim; 2004 Jun; 23(6):636-8. PubMed ID: 15234734
[No Abstract] [Full Text] [Related]
11. Impact of a long-term antibiotic stewardship program targeting fluoroquinolones in a French local hospital.
Muller A; Romand K; Suplisson D; Nattero JF; Leroy J; Bertrand X
Med Mal Infect; 2019 Sep; 49(6):442-446. PubMed ID: 30670316
[TBL] [Abstract][Full Text] [Related]
12. Effect of fluoroquinolone treatment on growth of and toxin production by epidemic and nonepidemic clostridium difficile strains in the cecal contents of mice.
Adams DA; Riggs MM; Donskey CJ
Antimicrob Agents Chemother; 2007 Aug; 51(8):2674-8. PubMed ID: 17562807
[TBL] [Abstract][Full Text] [Related]
13. Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution.
Cattaneo C; Quaresmini G; Casari S; Capucci MA; Micheletti M; Borlenghi E; Signorini L; Re A; Carosi G; Rossi G
J Antimicrob Chemother; 2008 Mar; 61(3):721-8. PubMed ID: 18218645
[TBL] [Abstract][Full Text] [Related]
14. Call for the international adoption of microbiological breakpoints for fluoroquinolones and Streptococcus pneumoniae.
Schurek KN; Adam HJ; Hoban DJ; Zhanel GG
Int J Antimicrob Agents; 2006 Sep; 28(3):266-9. PubMed ID: 16904294
[TBL] [Abstract][Full Text] [Related]
15. Preserving the efficacy of front-line fluoroquinolones through selective use to optimise clinical outcomes.
Lode HM
Int J Antimicrob Agents; 2014 Jun; 43(6):497-507. PubMed ID: 24787481
[TBL] [Abstract][Full Text] [Related]
16. Fluoroquinolones: then and now.
Pallo-Zimmerman LM; Byron JK; Graves TK
Compend Contin Educ Vet; 2010 Jul; 32(7):E1-9; quiz E9. PubMed ID: 20957609
[TBL] [Abstract][Full Text] [Related]
17. Bacterial resistance to fluoroquinolones: lessons to be learned.
Ball P
Infection; 1994; 22 Suppl 2():S140-7. PubMed ID: 7927833
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic resistance-the problem intensifies.
Levy SB
Adv Drug Deliv Rev; 2005 Jul; 57(10):1446-50. PubMed ID: 15949867
[TBL] [Abstract][Full Text] [Related]
19. Comparative dynamics of the emergence of fluoroquinolone resistance in staphylococci from the nasal microbiota of patients treated with fluoroquinolones according to their environment.
Munier AL; de Lastours V; Barbier F; Chau F; Fantin B; Ruimy R
Int J Antimicrob Agents; 2015 Dec; 46(6):653-9. PubMed ID: 26508586
[TBL] [Abstract][Full Text] [Related]
20. Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections.
Appelbaum PC
Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):5-16. PubMed ID: 19667544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
